A mutant KRAS-induced factor REG4 promotes cancer stem cell properties via Wnt/β-catenin signaling

Jeong Ha Hwang; Junyong Yoon; Yong Hee Cho; Pu Hyeon Cha; Jong Chan Park; Kang Yell Choi

doi:10.1002/ijc.32728

A mutant KRAS-induced factor REG4 promotes cancer stem cell properties via Wnt/β-catenin signaling

Jeong Ha Hwang, Junyong Yoon, Yong Hee Cho, Pu Hyeon Cha, Jong Chan Park, Kang Yell Choi

Research output: Contribution to journal › Article › peer-review

21 Citations (Scopus)

Abstract

Mutant KRAS provides a driving force for enhancement of cancer stem cells (CSCs) characteristics contributing transformation of colorectal cancer (CRC) cells harboring adenomatous polyposis coli (APC) mutations. Here, we identified the factors mediating the promotion of CSCs properties induced by KRAS mutation through microarray analyses of genes specifically induced in CRC spheroids harboring both KRAS and APC mutations. Among them, REG4 was identified as a key factor since CRISPR/Cas9-mediated knockout of REG4 most significantly affected the stem cell characteristics in which CSCs markers were effectively suppressed. We show that REG4 mediates promotion of CSCs properties via Wnt/β-catenin signaling in various in vitro studies including tumor organoid systems. Furthermore, expression patterns of CSCs markers and REG4 correlated in intestinal tumors from Apc^min/+/Kras^G12DLA2 mice and in CRC patient tissues harboring both KRAS and APC mutations. The role of REG4 in the tumor-initiating capacity accompanied by enhancement of CSCs characteristics was also revealed by NSG mice xenograft system. Collectively, our study highlights the importance of REG4 in promoting CSCs properties induced by KRAS mutation, and provides a new therapeutic strategy for CRC harboring both APC and KRAS mutations.

Original language	English
Pages (from-to)	2877-2890
Number of pages	14
Journal	International Journal of Cancer
Volume	146
Issue number	10
DOIs	https://doi.org/10.1002/ijc.32728
Publication status	Published - 2020 May 15

Bibliographical note

Funding Information:
We thank Dr. B. Vogelstein and K.W. Kinzler for providing the DLD‐1 isogenic cells. We also thank Dr. Y.‐Y. Kong for providing the B6.129P2‐ Lgr5 tm1 ( cre/ERT2 ) Cle /J ( Lgr5‐EGFP ) mice. This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean Government (MSIP) (grants 2016R1A5A1004694 and 2015R1A2A05001873; to K.Y. Choi). J.H. Hwang was supported by a Brain Korea 21 (BK21) Plus studentship from the NRF. This research was partially supported by the Graduate School of YONSEI University Research Scholarship Grants.

Funding Information:
We thank Dr. B. Vogelstein and K.W. Kinzler for providing the DLD-1 isogenic cells. We also thank Dr. Y.-Y. Kong for providing the B6.129P2-Lgr5tm1(cre/ERT2)Cle/J (Lgr5-EGFP) mice. This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean Government (MSIP) (grants 2016R1A5A1004694 and 2015R1A2A05001873; to K.Y. Choi). J.H. Hwang was supported by a Brain Korea 21 (BK21) Plus studentship from the NRF. This research was partially supported by the Graduate School of YONSEI University Research Scholarship Grants.

Publisher Copyright:
© 2019 UICC

All Science Journal Classification (ASJC) codes

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/ijc.32728

Cite this

@article{a8ac2a2cc1c64f50998f61c566ca16a7,

title = "A mutant KRAS-induced factor REG4 promotes cancer stem cell properties via Wnt/β-catenin signaling",

abstract = "Mutant KRAS provides a driving force for enhancement of cancer stem cells (CSCs) characteristics contributing transformation of colorectal cancer (CRC) cells harboring adenomatous polyposis coli (APC) mutations. Here, we identified the factors mediating the promotion of CSCs properties induced by KRAS mutation through microarray analyses of genes specifically induced in CRC spheroids harboring both KRAS and APC mutations. Among them, REG4 was identified as a key factor since CRISPR/Cas9-mediated knockout of REG4 most significantly affected the stem cell characteristics in which CSCs markers were effectively suppressed. We show that REG4 mediates promotion of CSCs properties via Wnt/β-catenin signaling in various in vitro studies including tumor organoid systems. Furthermore, expression patterns of CSCs markers and REG4 correlated in intestinal tumors from Apcmin/+/KrasG12DLA2 mice and in CRC patient tissues harboring both KRAS and APC mutations. The role of REG4 in the tumor-initiating capacity accompanied by enhancement of CSCs characteristics was also revealed by NSG mice xenograft system. Collectively, our study highlights the importance of REG4 in promoting CSCs properties induced by KRAS mutation, and provides a new therapeutic strategy for CRC harboring both APC and KRAS mutations.",

author = "Hwang, {Jeong Ha} and Junyong Yoon and Cho, {Yong Hee} and Cha, {Pu Hyeon} and Park, {Jong Chan} and Choi, {Kang Yell}",

note = "Funding Information: We thank Dr. B. Vogelstein and K.W. Kinzler for providing the DLD‐1 isogenic cells. We also thank Dr. Y.‐Y. Kong for providing the B6.129P2‐ Lgr5 tm1 ( cre/ERT2 ) Cle /J ( Lgr5‐EGFP ) mice. This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean Government (MSIP) (grants 2016R1A5A1004694 and 2015R1A2A05001873; to K.Y. Choi). J.H. Hwang was supported by a Brain Korea 21 (BK21) Plus studentship from the NRF. This research was partially supported by the Graduate School of YONSEI University Research Scholarship Grants. Funding Information: We thank Dr. B. Vogelstein and K.W. Kinzler for providing the DLD-1 isogenic cells. We also thank Dr. Y.-Y. Kong for providing the B6.129P2-Lgr5tm1(cre/ERT2)Cle/J (Lgr5-EGFP) mice. This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean Government (MSIP) (grants 2016R1A5A1004694 and 2015R1A2A05001873; to K.Y. Choi). J.H. Hwang was supported by a Brain Korea 21 (BK21) Plus studentship from the NRF. This research was partially supported by the Graduate School of YONSEI University Research Scholarship Grants. Publisher Copyright: {\textcopyright} 2019 UICC",

year = "2020",

month = may,

day = "15",

doi = "10.1002/ijc.32728",

language = "English",

volume = "146",

pages = "2877--2890",

journal = "International Journal of Cancer",

issn = "0020-7136",

publisher = "Wiley-Liss Inc.",

number = "10",

}

TY - JOUR

T1 - A mutant KRAS-induced factor REG4 promotes cancer stem cell properties via Wnt/β-catenin signaling

AU - Hwang, Jeong Ha

AU - Yoon, Junyong

AU - Cho, Yong Hee

AU - Cha, Pu Hyeon

AU - Park, Jong Chan

AU - Choi, Kang Yell

N1 - Funding Information: We thank Dr. B. Vogelstein and K.W. Kinzler for providing the DLD‐1 isogenic cells. We also thank Dr. Y.‐Y. Kong for providing the B6.129P2‐ Lgr5 tm1 ( cre/ERT2 ) Cle /J ( Lgr5‐EGFP ) mice. This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean Government (MSIP) (grants 2016R1A5A1004694 and 2015R1A2A05001873; to K.Y. Choi). J.H. Hwang was supported by a Brain Korea 21 (BK21) Plus studentship from the NRF. This research was partially supported by the Graduate School of YONSEI University Research Scholarship Grants. Funding Information: We thank Dr. B. Vogelstein and K.W. Kinzler for providing the DLD-1 isogenic cells. We also thank Dr. Y.-Y. Kong for providing the B6.129P2-Lgr5tm1(cre/ERT2)Cle/J (Lgr5-EGFP) mice. This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean Government (MSIP) (grants 2016R1A5A1004694 and 2015R1A2A05001873; to K.Y. Choi). J.H. Hwang was supported by a Brain Korea 21 (BK21) Plus studentship from the NRF. This research was partially supported by the Graduate School of YONSEI University Research Scholarship Grants. Publisher Copyright: © 2019 UICC

PY - 2020/5/15

Y1 - 2020/5/15

N2 - Mutant KRAS provides a driving force for enhancement of cancer stem cells (CSCs) characteristics contributing transformation of colorectal cancer (CRC) cells harboring adenomatous polyposis coli (APC) mutations. Here, we identified the factors mediating the promotion of CSCs properties induced by KRAS mutation through microarray analyses of genes specifically induced in CRC spheroids harboring both KRAS and APC mutations. Among them, REG4 was identified as a key factor since CRISPR/Cas9-mediated knockout of REG4 most significantly affected the stem cell characteristics in which CSCs markers were effectively suppressed. We show that REG4 mediates promotion of CSCs properties via Wnt/β-catenin signaling in various in vitro studies including tumor organoid systems. Furthermore, expression patterns of CSCs markers and REG4 correlated in intestinal tumors from Apcmin/+/KrasG12DLA2 mice and in CRC patient tissues harboring both KRAS and APC mutations. The role of REG4 in the tumor-initiating capacity accompanied by enhancement of CSCs characteristics was also revealed by NSG mice xenograft system. Collectively, our study highlights the importance of REG4 in promoting CSCs properties induced by KRAS mutation, and provides a new therapeutic strategy for CRC harboring both APC and KRAS mutations.

AB - Mutant KRAS provides a driving force for enhancement of cancer stem cells (CSCs) characteristics contributing transformation of colorectal cancer (CRC) cells harboring adenomatous polyposis coli (APC) mutations. Here, we identified the factors mediating the promotion of CSCs properties induced by KRAS mutation through microarray analyses of genes specifically induced in CRC spheroids harboring both KRAS and APC mutations. Among them, REG4 was identified as a key factor since CRISPR/Cas9-mediated knockout of REG4 most significantly affected the stem cell characteristics in which CSCs markers were effectively suppressed. We show that REG4 mediates promotion of CSCs properties via Wnt/β-catenin signaling in various in vitro studies including tumor organoid systems. Furthermore, expression patterns of CSCs markers and REG4 correlated in intestinal tumors from Apcmin/+/KrasG12DLA2 mice and in CRC patient tissues harboring both KRAS and APC mutations. The role of REG4 in the tumor-initiating capacity accompanied by enhancement of CSCs characteristics was also revealed by NSG mice xenograft system. Collectively, our study highlights the importance of REG4 in promoting CSCs properties induced by KRAS mutation, and provides a new therapeutic strategy for CRC harboring both APC and KRAS mutations.

UR - http://www.scopus.com/inward/record.url?scp=85075421164&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075421164&partnerID=8YFLogxK

U2 - 10.1002/ijc.32728

DO - 10.1002/ijc.32728

M3 - Article

C2 - 31605540

AN - SCOPUS:85075421164

SN - 0020-7136

VL - 146

SP - 2877

EP - 2890

JO - International Journal of Cancer

JF - International Journal of Cancer

IS - 10

ER -

A mutant KRAS-induced factor REG4 promotes cancer stem cell properties via Wnt/β-catenin signaling

Abstract

Bibliographical note

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this